Insider Transactions in Q3 2024 at Intellia Therapeutics, Inc. (NTLA)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 22
2024
|
Edward J Dulac Iii EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,324
+50.0%
|
-
|
|
Jul 01
2024
|
Michael P Dube VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,801
+26.64%
|
-
|
|
Jul 01
2024
|
Eliana Clark EVP, Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
405
-0.56%
|
$8,910
$22.93 P/Share
|